Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on depression and currently lists participation information in the United States.
Multiple locations, including San FranciscoThis study is recruiting. It focuses on depression and currently lists participation information in Canada.
In TorontoThis study is recruiting. It focuses on anxiety and currently lists participation information in Malawi.
In MalawiThis study is recruiting. It focuses on anxiety and currently lists participation information in Afghanistan and France.
In AfghanistanThis study is recruiting. It focuses on depression and currently lists participation information in China.
In Hangzhou
This study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United Kingdom
This study is recruiting. It focuses on depression and currently lists participation information in Germany.
In GermanyThis study is recruiting in the United Kingdom. It is testing an aripiprazole and sertraline drug combination for depression in bipolarity.
In United KingdomThis study is recruiting. It focuses on depression and currently lists participation information in France.
In LilleThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
Multiple locations, including Chino
This study is recruiting in the United Kingdom and in Ireland. It focuses on depression.
In United KingdomThis study is recruiting in the United Kingdom. It is testing repetitve transcranial magnetic stimulation for depression.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.